Melinta Therapeutics Announces FDA Acceptance of Investigational New Drug Application for Topical Radezolid

World News: . []

NEW HAVEN Conn Feb 28 2017 GLOBE NEWSWIRE -- a privately held company developing novel antibiotics to treat serious bacterial infections announced today the US Food and Drug Administration FDA has accepted an Investigational New Drug (IND) ...

More news and information about Melinta Therapeutics

Published By:

Globe Newswire: 13:00 GMT Tuesday 28th February 2017

Published: .

Search for other references to "melinta" on SPi News


Share

Previous StoryNext Story

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.
 
Privacy Policy | Terms and Conditions | Contact Us